Current Controversies and Challenges in Brugada Syndrome
More than three decades since its initial description in 1993, Brugada syndrome remains engulfed in controversy. This review aims to shed light on the main challenges surrounding the diagnostic pathway and criteria, risk stratification of asymptomatic patients, pharmacological and interventional ris...
Saved in:
Main Authors: | Afik D Snir, Hariharan Raju |
---|---|
Format: | article |
Language: | EN |
Published: |
Radcliffe Medical Media
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/924ef43354f64c3f9518a0efa09e1a0e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insights for Stratification of Risk in Brugada Syndrome
by: Daniel García Iglesias, et al.
Published: (2019) -
Brugada Syndrome: Progress in Diagnosis and Management
by: Carlo Pappone, et al.
Published: (2019) -
Brugada Syndrome: Progress in Genetics, Risk Stratification and Management
by: Jorge Romero, et al.
Published: (2019) -
Featuring: Josep Brugada
by: Josep Brugada
Published: (2019) -
Type‐I Paradox of Brugada Syndrome
by: Sami Viskin, et al.
Published: (2018)